SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against UnitedHealth Group Inc. - UNH

Group 1 - A class action lawsuit has been filed against UnitedHealth Group Inc. for alleged securities fraud and unlawful business practices [1] - The lawsuit allows shareholders who purchased UnitedHealth securities during the Class Period to seek appointment as Lead Plaintiff by July 15, 2024 [1] - The U.S. Department of Justice has initiated an antitrust investigation into UnitedHealth, focusing on its health services arm, Optum [2] Group 2 - Following the news of the antitrust investigation, UnitedHealth's stock price dropped by $27.04, or 5.15%, closing at $498.28 per share on February 28, 2024 [2] - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having recovered billions in damages for class members [3]